Paul J. Hastings

Companies

• enGene Therapeutics Inc.Board member May 17, 2024 to now¹
• Nkarta Therapeutics (United States)Chief executive officer Jan 12, 2021 to now²
• Nkarta Therapeutics (United States)Board member Jul 9, 2020 to now³
• Pacira BioSciences, Inc.Board member Jun 6, 2011 to Jun 13, 2024⁴
• Nkarta Therapeutics (United States)Officer Jul 9, 2020 to Jul 13, 2020³
• Proteon TherapeuticsBoard member Oct 20, 2016 to Jun 11, 2018⁵
• OncoMedChair Mar 27, 2014 to Oct 12, 2017⁶
• OncoMedChief executive officer Jul 17, 2013 to Oct 12, 2017⁷
• OncoMedBoard member Jul 17, 2013 to Mar 25, 2016⁷
• OncoMedPresident Jul 17, 2013 to Jul 23, 2013⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NTNkarta Therapeutics (United States) NKTX390,247 shares⁸$696.6K at $1.78Jun 18, 2026
• PBPacira BioSciences, Inc. PCRX12,724 shares⁹$462.6K at $36.36Jun 13, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 18, 2026Sold 1,776 shares at $2.71 of Nkarta Therapeutics (United States)⁸
• Jan 15, 2026Sold 26,046 shares at $2.07 of Nkarta Therapeutics (United States)¹⁰
• Jan 6, 2026Granted 94,000 shares of Nkarta Therapeutics (United States)¹¹
• Jun 18, 2025Sold 1,790 shares at $1.79 of Nkarta Therapeutics (United States)¹²
• Jan 15, 2025Sold 17,378 shares at $2.20 of Nkarta Therapeutics (United States)¹³
• Jan 3, 2025Granted 94,500 shares of Nkarta Therapeutics (United States)¹⁴
• Jun 18, 2024Sold 1,770 shares at $5.60 of Nkarta Therapeutics (United States)¹⁵
• Jun 13, 2024Sold 880 shares at $28.38 of Pacira BioSciences, Inc.⁹
• Jun 12, 2024Granted 5,230 shares of Pacira BioSciences, Inc.⁹
• Mar 4, 2024Returned to company 137,642 shares at $13.33 of Nkarta Therapeutics (United States)¹⁶
• Mar 1, 2024Returned to company 12,358 shares at $13.00 of Nkarta Therapeutics (United States)¹⁶
• Jan 16, 2024Sold 9,697 shares at $8.74 of Nkarta Therapeutics (United States)¹⁷
• Jan 4, 2024Granted 85,000 shares of Nkarta Therapeutics (United States)¹⁸
• Jun 20, 2023Sold 1,704 shares at $4.85 of Nkarta Therapeutics (United States)¹⁹
• Jun 14, 2023Granted 1,775 shares of Pacira BioSciences, Inc.²⁰
• Jun 5, 2023Sold 580 shares at $38.34 of Pacira BioSciences, Inc.²¹
• May 15, 2023Sold 7,000 shares at $41.85 of Pacira BioSciences, Inc.²²
• May 15, 2023Exercised options 7,000 shares at $29.90 of Pacira BioSciences, Inc.²²
• Jan 17, 2023Sold 3,691 shares at $5.49 of Nkarta Therapeutics (United States)²³
• Jan 13, 2023Granted 64,500 shares of Nkarta Therapeutics (United States)²³
• Sep 29, 2022Sold 498 shares at $13.00 of Nkarta Therapeutics (United States)²⁴
• Sep 28, 2022Sold 23,376 shares at $13.03 of Nkarta Therapeutics (United States)²⁴
• Sep 21, 2022Sold 6,126 shares at $13.01 of Nkarta Therapeutics (United States)²⁵
• Jul 11, 2022Sold 533 shares at $56.95 of Pacira BioSciences, Inc.²⁶
• Jun 17, 2022Granted 19,500 shares of Nkarta Therapeutics (United States)²⁷